Executive Leadership Team
Our day-to-day activities are managed by the Executive team, which is made up of senior managers from across the organisation.
Director of the Wellcome Trust
Before joining Wellcome in October 2013, Jeremy was Director of the Oxford University Clinical Research Unit in Vietnam for 18 years. His research interests were infectious diseases, tropical health and emerging infections. He has published over 500 peer-reviewed scientific papers, mentored many dozens of students and fellows, and served as Chair on several advisory boards for governments and global organisations, including the World Health Organization. He was named 12th in Fortune's list of the World's 50 Greatest Leaders in 2015.
Jeremy was appointed OBE in 2005 for services to tropical medicine, was awarded the Memorial Medal and the Ho Chi Minh City Medal by the Government of Vietnam, and has been honoured by the Royal College of Physicians in the UK and the American Society for Tropical Medicine and Hygiene. He is a Fellow of both the Academy of Medical Sciences and the Royal Society.
Jeremy is married with three children. He loves all sport and walking in the Alps.
General Counsel and Company Secretary
Chris is Wellcome's senior legal adviser, and is responsible for managing all the legal needs of Wellcome and its subsidiaries.
During his time here, Chris has been involved in and led some of our highest profile projects and policy interests.
Before joining Wellcome in 2000, Chris was an Associate Solicitor with Osborne Clarke LLP.
Director of Innovations
Stephen joined Wellcome in June 2015. Previously, he was Vice Provost (Enterprise & London) and Vernon Professor of Organic Chemistry and Chemical Biology at University College London.
Stephen is a member of the Scientific Advisory Board for MRC Technology. He is co-founder of Synthetic Pages, an open access website, and Thiologics, an antibody-drug conjugate (ADC) biotech spinout company. His laboratory focuses on chemical modification of proteins and antibodies for development of therapeutics and diagnostics.
He has played an important role in the development of the chemical biology strategy and facilities in the Francis Crick Institute.
Director of Culture & Society
Simon joined Wellcome in February 2010. Before taking up his current role in November 2014, he was head of the Wellcome Library, where he led a highly successful digitisation programme and an exciting redesign of the library's public spaces.
Simon originally studied zoology, before an interest in the history of science and medicine led him to join the Science Museum, where he worked on the Wellcome medical collections and managed the PRISM Grant Fund for preservation of industrial and scientific material.
Before joining Wellcome, Simon was Director of Museums and Special Collections at the Royal College of Surgeons, where he led the curatorial team responsible for the redevelopment of the Hunterian Museum.
His academic research interests include the history of anatomy and medical museums.
Director of Grants Management
Alyson joined Wellcome in November 2010. She has responsibility for the management and governance of our grant funding and review processes.
Before Wellcome, she pursued a research career, at University College London and Imperial College, and then in the pharma industry. Alyson spent 13 years working in drug discovery at Novartis, ultimately leading a therapeutic area responsible for a portfolio of projects from target discovery and preclinical development to clinical trials.
She has experience in neuroscience, respiratory and gastrointestinal research areas.
Joint Managing Partner of Investments
Peter Pereira Gray
Peter joined Wellcome in January 2001. He works with a team managing Wellcome's £20 billion multi-asset global investment portfolio. Peter's day-to-day responsibilities include overseeing Wellcome's privately held assets (private equity, real estate, venture capital and private direct holdings). In addition, he is Chair of the farming and land management business, FarmCare Ltd, and of Premier Marinas Ltd. Peter is also a Main Board Director of Vero Group Limited, the newly formed student housing joint venture with Goldman Sachs.
He is a life member and past Chair of the Investment Property Forum, a past founding and advisory board member and member of the management board of INREV, a member of the Bank of England Commercial and Residential Property Forums, and a Fellow of the Royal Institution of Chartered Surveyors.
Peter is also an Advisory Board member for Composition Capital Partners, an honorary vice-president of Cambridge University Land Society, a Life Fellow of the Royal Society of Arts, and an Advisory Board member and Honorary Fellow of the Institute of Continuing Professional Development.
Director of Communications
Mark leads all aspects of our communications, with a particular focus on building and sustaining Wellcome's reputation and influence so that our work contributes more to health and society. His team's responsibilities include brand, media relations, digital products, content, campaigns, design and understanding our audiences.
Mark joined Wellcome in 2012. Before that, he had a 15-year career in journalism at The Times of London, where he was Science Editor and won several awards for his reporting.
He has written two books: 'The Geek Manifesto: Why Science Matters', which explores the relationship between science and politics, and '50 Genetics Ideas You Really Need to Know'. He is an avid skier.
Director of Insight and Analysis
Chonnettia joined Wellcome in 2012. She has responsibility for assessing the performance and impact of our funded research and activities. Before taking up this role in January 2016, she headed the science integration team, which managed the coordination, monitoring and assessment of major science funding initiatives.
Before Wellcome, Chonnettia studied developmental neurobiology as a Ruth L. Kirschstein research fellow at Emory University. She went on to lecture at American universities before managing a collaborative scientific research programme at the Janelia Research Campus of the Howard Hughes Medical Institute.
Chonnettia is an active mentor, and has acquired a new interest in history and architecture since moving to London to complement her love of travel.
Chief Financial Officer
Tim joined Wellcome in December 2014 and is responsible for the leadership of the Finance and IT departments.
After graduating in chemistry, he joined ICI/Zeneca and trained as an accountant. He has spent the majority of his career in commercial aviation, working for British Airways and, after a short break, at Virgin Atlantic, most recently in the role of Chief Financial Officer.
Joint Managing Partner of Investments
Nick is directly responsible for Wellcome's global equity, FX and derivatives exposure, as well as playing a key role in broader investment strategy and management of the Investment Team. He is a member of our Investment Committee.
Nick joined Wellcome in 2007 from BlackRock Investment Management where he was Head of the Asia Pacific investment team and co-head of Emerging Markets. He has 27 years' professional experience in Asia, and 22 years' experience in global equity markets.
He graduated in Modern History and Economics from Balliol College, Oxford, and is a CFA charter holder. Before joining BlackRock in 1997, Nick lived in Hong Kong for nine years. He is a Chinese speaker. He started his career in the Diplomatic Service.
Nick is Chair of the Imperial College London Endowment Fund and a Non-Executive Director of the Foreign and Colonial Investment Trust. He's also a Board Member of the UK Investor Forum, which aims to align the interests of listed companies and long-term shareholders.
Director of Science
Jim joined Wellcome's leadership team on 1 December 2016. He's responsible for leading the Science Division, developing Wellcome's science research strategy and managing a broad research portfolio.
A globally recognised developmental biologist, Jim's research interests include inductive interactions in vertebrate development and applying the principles of developmental biology to stem cell differentiation.
His previous roles include Director of the Wellcome Trust/Cancer Research UK Gurdon Institute and Director of the MRC National Institute for Medical Research (NIMR), where he oversaw its transition to the Francis Crick Institute. More recently, he has been Deputy CEO and Chief of Strategy at the Medical Research Council, and Director of Research and Group Leader at the Francis Crick Institute.
Jim has a distinguished career in scientific research as a Fellow of the Royal Society (1993), a Fellow of the Academy of Medical Sciences (1998) and a member of the Academia Europaea (2000). He has also been awarded the EMBO Medal (1993) and the Waddington Medal (2013). Jim was knighted in the 2017 Queen's New Year's Honours list.
Jim has kept his lab at the Francis Crick Institute but is no longer a Crick employee or part of its leadership team. In line with our Conflict of Interest Policy [PDF 181KB], he will play no part in any Wellcome funding decisions related to the Francis Crick Institute or its employees.
Director of People & Facilities
Ted joined Wellcome at the beginning of 2015. He has responsibility for buildings, travel, health and safety, meetings, catering and cleaning services, internal communications, and human resources.
For the previous five years, Ted had worked as Group HR Director of the Medical Research Council.
He has also worked at Glaxo Group Research, GlaxoWellcome and GSK (where his last role was as Vice President HR), at two market research companies, and at Vernalis, a Cambridge-based biotech company. Ted has also held trustee roles at two charities, Wysing Arts and Herts Careers Service.
He has a degree in Science and the Environment, and a love of live music, photography and sport.
Chief Technology Officer
James joined Wellcome in April 2016. He is responsible for leadership of our technology and digital services.
Before Wellcome, James had an extensive career in the private and public sectors, delivering transformational change through technology and data.
His career began in the oil and water industries, with BP and Veolia. He moved to global technology provider Oracle to develop and lead technology consulting services for clients, including banking, defence and manufacturing.
He then moved into healthcare, with technology leadership roles in the NHS. This included eight years as a Director of UCL Hospitals, establishing UCL Partners, London NHS Procurement Partnership and the UCH Macmillan Cancer Centre. Following this, James became an Associate Partner at Atos Consulting, including working with Genomics England to review its Informatics and bioinformatics capabilities.
Joint Managing Partner of Investments
Danny joined Wellcome in 2005, having previously been a Managing Director of Goldman Sachs in its investment management division. Before joining Goldman Sachs in 1996, Danny's career was focused on Asian financial markets.
Director of Policy and Chief of Staff
Ed joined Wellcome in September 2016. He has worked in a number of Whitehall social and financial policy departments during his civil service career, including HM Treasury's financial stability team during the 2008-09 financial crisis. He was most recently at 10 Downing Street as Deputy Principal Private Secretary to the Prime Minister, leading on public services.
In addition to his civil service career, in 2011-12 Ed set up and ran a small arts crowdfunding website. In 2012-13 he was an elected member of the RSA's Fellowship Council.
Ed was awarded an OBE for public service and services to 10 Downing Street in the June 2016 Queen's Birthday Honours list.